Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications
Chinese EV maker Geely expands into Brazil through a partnership with France’s Renault; The parent company of Calvin Klein and Tommy Hilfiger is blacklisted by China; and Canadian Solar is sued by China’s Trina Solar over patent infringement.
In 2024, significant progress was made in the fields of legislation, merger control, administrative enforcement, and litigation under the PRC Anti-Monopoly Law. Huang Wei, Gao Chang, Zhu Fan and Ren Yuying of Tian Yuan Law Firm set out an overview of the major developments and key takeaways
The sudden rise of DeepSeek AI has prompted regulators’ concerns over its processing of data; the EU plans to ensure e-commerce platforms are compliant with its laws; and U.S.-China tensions are pushing China-focused private equity funds to expand beyond China.
Jianwei (Jerry) Fang, Chuchen (Julie) Hou and Jiaying (Kate) Jiang of Zhong Lun Law Firm discuss last year’s most significant legislative and judicial developments in civil and commercial dispute resolution in China
In 2024, the U.S. continued placing wide-ranging restrictions on Chinese interests. What made that year different was the impact those restrictions have on third countries. Charles Wu of Clyde & Co reviews the legislative changes, and offers practical insights into their potential impact with a focus on third countries, and the path forward in 2025
Chinese cybersecurity regulator details on the lenient certification method for cross-border data transfer; U.S. issues final rule to prevent “adversarial nations” accessing U.S. citizens’ sensitive personal data; and U.S. to ban venture capital funds from backing certain PLA-affiliated companies
Personal information handlers of the Greater Bay Area are required to make publicly available its rules for processing personal information / CLP Reference: 5600/24.11.21, Issued: 2024-11-21
While companies from third countries do not necessarily need to divest from China to invest in the U.S., they should be prepared for CFIUS scrutiny of their China operations
State Intellectual Property Office issues guidelines on AI as patent inventors; German and British companies are less optimistic about their China prospects, with a caveat; and U.S. adds a range of companies involved in Chinese chipmaking to Entity List